FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2753321278> ?p ?o ?g. }

• W2753321278 abstract "Renin-angiotensin system (RAS) signaling and angiotensin-converting enzyme 2 (ACE2) have been implicated in the pathogenesis of acute respiratory distress syndrome (ARDS). We postulated that repleting ACE2 using GSK2586881, a recombinant form of human angiotensin-converting enzyme 2 (rhACE2), could attenuate acute lung injury. We conducted a two-part phase II trial comprising an open-label intrapatient dose escalation and a randomized, double-blind, placebo-controlled phase in ten intensive care units in North America. Patients were between the ages of 18 and 80 years, had an American-European Consensus Criteria consensus diagnosis of ARDS, and had been mechanically ventilated for less than 72 h. In part A, open-label GSK2586881 was administered at doses from 0.1 mg/kg to 0.8 mg/kg to assess safety, pharmacokinetics, and pharmacodynamics. Following review of data from part A, a randomized, double-blind, placebo-controlled investigation of twice-daily doses of GSK2586881 (0.4 mg/kg) for 3 days was conducted (part B). Biomarkers, physiological assessments, and clinical endpoints were collected over the dosing period and during follow-up. Dose escalation in part A was well-tolerated without clinically significant hemodynamic changes. Part B was terminated after 39 of the planned 60 patients following a planned futility analysis. Angiotensin II levels decreased rapidly following infusion of GSK2586881, whereas angiotensin-(1–7) and angiotensin-(1–5) levels increased and remained elevated for 48 h. Surfactant protein D concentrations were increased, whereas there was a trend for a decrease in interleukin-6 concentrations in rhACE2-treated subjects compared with placebo. No significant differences were noted in ratio of partial pressure of arterial oxygen to fraction of inspired oxygen, oxygenation index, or Sequential Organ Failure Assessment score. GSK2586881 was well-tolerated in patients with ARDS, and the rapid modulation of RAS peptides suggests target engagement, although the study was not powered to detect changes in acute physiology or clinical outcomes. ClinicalTrials.gov, NCT01597635 . Registered on 26 January 2012." @default.
• W2753321278 created "2017-09-15" @default.
• W2753321278 creator A5002847672 @default.
• W2753321278 creator A5009100376 @default.
• W2753321278 creator A5011032957 @default.
• W2753321278 creator A5012242776 @default.
• W2753321278 creator A5012378798 @default.
• W2753321278 creator A5015497968 @default.
• W2753321278 creator A5018321818 @default.
• W2753321278 creator A5029172499 @default.
• W2753321278 creator A5039953780 @default.
• W2753321278 creator A5041750131 @default.
• W2753321278 creator A5042741758 @default.
• W2753321278 creator A5055706380 @default.
• W2753321278 creator A5064895812 @default.
• W2753321278 creator A5067261736 @default.
• W2753321278 creator A5067380534 @default.
• W2753321278 creator A5067861844 @default.
• W2753321278 creator A5070182407 @default.
• W2753321278 creator A5077430660 @default.
• W2753321278 date "2017-09-07" @default.
• W2753321278 modified "2023-10-03" @default.
• W2753321278 title "A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome" @default.
• W2753321278 cites W1539754353 @default.
• W2753321278 cites W1964982019 @default.
• W2753321278 cites W1979019728 @default.
• W2753321278 cites W1979749207 @default.
• W2753321278 cites W1986652184 @default.
• W2753321278 cites W1987195754 @default.
• W2753321278 cites W1988567483 @default.
• W2753321278 cites W1992173844 @default.
• W2753321278 cites W2015124236 @default.
• W2753321278 cites W2028439883 @default.
• W2753321278 cites W2033190476 @default.
• W2753321278 cites W2040263832 @default.
• W2753321278 cites W2051332153 @default.
• W2753321278 cites W2057181580 @default.
• W2753321278 cites W2058713776 @default.
• W2753321278 cites W2063299162 @default.
• W2753321278 cites W2074400408 @default.
• W2753321278 cites W2081621357 @default.
• W2753321278 cites W2093402003 @default.
• W2753321278 cites W2105400389 @default.
• W2753321278 cites W2107668920 @default.
• W2753321278 cites W2112443030 @default.
• W2753321278 cites W2124579702 @default.
• W2753321278 cites W2134540051 @default.
• W2753321278 cites W2136413073 @default.
• W2753321278 cites W2136725726 @default.
• W2753321278 cites W2149146712 @default.
• W2753321278 cites W2150193183 @default.
• W2753321278 cites W2156240908 @default.
• W2753321278 cites W2160670907 @default.
• W2753321278 cites W2161328469 @default.
• W2753321278 cites W2166849256 @default.
• W2753321278 cites W2255789882 @default.
• W2753321278 cites W2257418120 @default.
• W2753321278 cites W2288554080 @default.
• W2753321278 cites W4292528167 @default.
• W2753321278 doi "https://doi.org/10.1186/s13054-017-1823-x" @default.
• W2753321278 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5588692" @default.
• W2753321278 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28877748" @default.
• W2753321278 hasPublicationYear "2017" @default.
• W2753321278 type Work @default.
• W2753321278 sameAs 2753321278 @default.
• W2753321278 citedByCount "486" @default.
• W2753321278 countsByYear W27533212782017 @default.
• W2753321278 countsByYear W27533212782018 @default.
• W2753321278 countsByYear W27533212782019 @default.
• W2753321278 countsByYear W27533212782020 @default.
• W2753321278 countsByYear W27533212782021 @default.
• W2753321278 countsByYear W27533212782022 @default.
• W2753321278 countsByYear W27533212782023 @default.
• W2753321278 crossrefType "journal-article" @default.
• W2753321278 hasAuthorship W2753321278A5002847672 @default.
• W2753321278 hasAuthorship W2753321278A5009100376 @default.
• W2753321278 hasAuthorship W2753321278A5011032957 @default.
• W2753321278 hasAuthorship W2753321278A5012242776 @default.
• W2753321278 hasAuthorship W2753321278A5012378798 @default.
• W2753321278 hasAuthorship W2753321278A5015497968 @default.
• W2753321278 hasAuthorship W2753321278A5018321818 @default.
• W2753321278 hasAuthorship W2753321278A5029172499 @default.
• W2753321278 hasAuthorship W2753321278A5039953780 @default.
• W2753321278 hasAuthorship W2753321278A5041750131 @default.
• W2753321278 hasAuthorship W2753321278A5042741758 @default.
• W2753321278 hasAuthorship W2753321278A5055706380 @default.
• W2753321278 hasAuthorship W2753321278A5064895812 @default.
• W2753321278 hasAuthorship W2753321278A5067261736 @default.
• W2753321278 hasAuthorship W2753321278A5067380534 @default.
• W2753321278 hasAuthorship W2753321278A5067861844 @default.
• W2753321278 hasAuthorship W2753321278A5070182407 @default.
• W2753321278 hasAuthorship W2753321278A5077430660 @default.
• W2753321278 hasBestOaLocation W27533212781 @default.
• W2753321278 hasConcept C111113717 @default.
• W2753321278 hasConcept C112705442 @default.
• W2753321278 hasConcept C126322002 @default.
• W2753321278 hasConcept C142724271 @default.
• W2753321278 hasConcept C177713679 @default.
• W2753321278 hasConcept C198710026 @default.
• W2753321278 hasConcept C204787440 @default.

• next